SELLAS Life Sciences Group, Inc. (NASDAQ:SLS)
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), ended its previous trading session at $3.48 showing a gain of 0.25 or 7.74 percent with respect to the price of $3.23 when stock market opened. The company traded 483309 shares over the course of the trading day. Giving the average volume of 483.79 Million over the course of 3 consecutive months. Which signifies a pretty good change over the time with its shares outstanding of 6.38 Million.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) is currently trading Higher than its price target which is set to $0 by the analyst. The stock is -91.75% Below its 1-Year High which is $42.19. SLS has a difference of 139.18% from its 1 year low which stands at $1.46. The company is currently rated by analyst who are keeping a close eye on the stock as 2. Where 1 means Buy, 2.5 meaning Hold and 5 as Sell.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Performance Snapshot
The stock performed exceptionally bad in the previous week which depicts an decrease of 21.25 percent in the shares price. The company added about 95.51% in its share price over 1-Month. While taking about the performance of the stock over 1-year interval is -91.41 Percent. SLS currently shows -19.07% as its year to date performance.
SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) Price Insight
The stock needs to grow about $-3.48 to reach its price target. In order to seek the stock’s directional movements, 20-Days, 50 Days and 200-Days moving averages are 34.54%, 66.99% and -18.89 percent respectively. The stock trades about 3.32 percent of its Float giving its total shares Outstanding are 6.38 Million. SLS lost about -20.73 percent in 6 months showing its Average True Range of 0.26. The company currently has a RSI and Beta of 79.67 and 1.58.
While talking about SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) valuation ratios, the stock trades with a P/S and P/B of 0 and 2.76 which is significantly better and attractive as compared to its peers.
Performance Indicators of Sotheby’s (NYSE:BID)
Sotheby’s (NYSE:BID) Analytical Review